FITC Anti-Mouse/Human CD44 Antibody[IM7]

The FITC Anti-Mouse/Human CD44 Antibody [IM7] is a highly specific and reliable tool designed for the detection and analysis of CD44 expression in both mouse and human samples. This antibody is conjugated with FITC, a fluorescent dye that allows for easy visualization and quantification of CD44-positive cells.

CD44 is a cell surface glycoprotein that plays a crucial role in cell adhesion, migration, and signaling. It is involved in various physiological and pathological processes, including embryogenesis, inflammation, and cancer metastasis. The IM7 antibody specifically recognizes an epitope on CD44, making it an ideal choice for studying CD44 expression and function.

The FITC conjugation of this antibody provides several advantages. Firstly, it enables direct visualization of CD44-positive cells using fluorescence microscopy or flow cytometry. This allows for the identification and enumeration of CD44-expressing cells in complex samples, such as blood or tissue. Additionally, the FITC label provides excellent stability and brightness, ensuring accurate and reproducible results.

The IM7 antibody has been extensively validated for its specificity and sensitivity. It exhibits minimal cross-reactivity with other antigens, ensuring reliable and specific detection of CD44. Furthermore, it has been tested in a variety of applications, including immunohistochemistry, immunofluorescence, and flow cytometry, demonstrating its versatility and robust performance.

This antibody is supplied as a ready-to-use solution, eliminating the need for time-consuming and error-prone conjugation procedures. It is provided in a convenient format, allowing for easy integration into existing experimental protocols.

In summary, the FITC Anti-Mouse/Human CD44 Antibody [IM7] is a highly specific and reliable tool for the detection and analysis of CD44 expression. Its conjugation with FITC enables direct visualization and quantification of CD44-positive cells, making it an invaluable resource for researchers studying CD44 biology in both mouse and human samples.